Publications by authors named "Robert Gale"

Claim this Profile
D
Daratumumab in relapsed or refractory immune thrombocytopenic purpura.
Ciprian Tomuleasa, Robert Peter Gale

Blood Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking End Points in Modern Oncology Trials-Beyond the P Value.
Qiujin Shen, Robert Peter Gale, Junren Chen

JAMA Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Targeted Therapy Strategy for Lymphoma.
Robert Peter Gale

MedComm (2020)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
40 years of LEUKEMIA.
Andreas Hochhaus, Robert Peter Gale

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.
Edward A Copelan, Belinda R Avalos, Robert P Gale

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do ionizing radiations from inter-planetary travel cause leukaemia?
Christophe Badie, Robert Peter Gale

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia.
Mei Bao, Xiao S Zhang, Zong R Li, Lu Yu, Robert Peter Gale

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm.
Giovanni Barosi, Vittorio Rosti, Rita Campanelli, Margherita Massa, Carlotta Abbà, Robert Peter Gale

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.
Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas, Alberto Alvarez-Larran, Prithviraj Bose, Robert Peter Gale

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation in first relapse of (CBF- and other) AML.
Edward A Copelan, Robert P Gale

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.
Yun Wang, Shuzhao Chen, Zhijian Liang, Robert Peter Gale, Shutong Liu

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are real world data real world data?
Robert Peter Gale, Andreas Hochhaus

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.
Mengyao Yuan, Li Zhou, Weiming Li, Xin Du, Jianyu Weng, Robert Peter Gale

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in children with advanced idiopathic thrombocytopenic purpura.
Robert Peter Gale

Blood Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune therapy of haematological cancers.
Bin Pan, Robert Peter Gale

Best Pract Res Clin Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.
Qiujin Shen, Xiaowen Gong, Wei Zhang, Yu Hu, Yueshen Ma, Robert Peter Gale

JMIR Res Protoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the cancer vaccine landscape.
Fang Hu, Huan Li, Weiran Lv, Mengjing Li, Robert Peter Gale

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants.
Junren Chen, Yigeng Cao, Yahui Feng, Saibing Qi, Donglin Yang, Robert Peter Gale

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting survival of persons with newly-diagnosed multiple myeloma.
Limei Zhang, Yun Wang, Robert Peter Gale, Yang Liang

Cancer Cell Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.
Qiujin Shen, Xiaowen Gong, Wei Zhang, Yu Hu, Yueshen Ma, Robert Peter Gale

JMIR Res Protoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of patients' characteristics, treatment, and survival outcomes in CLL from China and the United States.
Yuting Yan, Yin Liu, Tonglu Qiu, Fan Yang, Jiamei Liu, Robert Peter Gale

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative-Donor Transplants in Adults ≤ 55 Years Old With Haematological Cancers: Young Versus Older Related HLA-Haplotype-Mismatched Donor Versus Unrelated Umbilical Cord Blood.
Yu Hu, Sichang Liu, Wangsong Zhai, Saibing Qi, Wei Zhang, Robert Peter Gale

Clin Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological Cancer.
Mohammadamin Noorafrooz, Robert Peter Gale, Mohadese Dashtkoohi

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface.
Thomas R Spitzer, Hillard M Lazarus, Robert Peter Gale

Best Pract Res Clin Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-NK cells for haematological cancers.
Mohammadamin Noorafrooz, Robert Peter Gale, Ramin Noorafrooz, Sanaz Ghods

Best Pract Res Clin Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis